Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings

References

• [ADA] American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et alConsensus development conference on antipsychotic drugs and obesity and diabetesDiabetes Care20042759660114747245
   PubMed Web of Science ®Google Scholar
• Aranceta-BartrinaJSerra-MajemLlFoz-SalaMPrevalencia de obesidad en EspañaMed Clin (Barc)2005125460616216203
   PubMed Web of Science ®Google Scholar
• BabidgeNCBuhrichNButlerTMortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-upActa Psychiatr Scand20011031051011167312
   PubMed Web of Science ®Google Scholar
• BarnettMArgoTAlexanderBA regional comparison of developing diabetes among Veterans Affairs patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitorsAnn Clin Psychiatry2006181716517447
   PubMedGoogle Scholar
• DincaOPaulMSpencerNJSystematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disordersJ Psychopharmacol2005195213216166190
   PubMed Web of Science ®Google Scholar
• FentonWSChavezMRMedication-induced weight gain and dyslipidemia in patients with schizophreniaAm J Psychiatry20061631697170417012676
   PubMed Web of Science ®Google Scholar
• Flores-MenesesLSanmarti-SalaAAtypical antipsychotics: new aetiology in type 2 diabetes mellitusMed Clin (Barc)2005124341315760602
   PubMed Web of Science ®Google Scholar
• Garcia-CardonaFMolins-PerezGFarre-PradellJCost accountability in primary care: list of servicesAten Primaria19951614157647208
   PubMedGoogle Scholar
• GómezPFernández de la PueblaRACastroPEffect of the Mediterranean diet on fasting concentrations of activated factor VII in healthy personsRev Esp Cardiol200558285915766451
   PubMed Web of Science ®Google Scholar
• Guallar-CastillónPBanegas-BanegasJRGarcía-YébenesMJAsociación de la enfermedad cardiovascular con el sobrepeso y la obesidad en EspañaMed Clin (Barc)20021186161812028914
   PubMed Web of Science ®Google Scholar
• Gutiérrez-FisacJLRegidorERodríguez-ArtalejoFPrevalencia de obesidad en la población adulta española: 14 años de incremento continuadoMed Clin (Barc)20051241967
   PubMed Web of Science ®Google Scholar
• HaggSLindblomYMjorndalTHigh prevelence of the metabolic syndrome among a Swedish cohort of patients with schizophreniaInt Clin Psychopharmacol20062193816421460
   PubMed Web of Science ®Google Scholar
• HauptDWDifferential metabolic effects of antipsychotic treatmentsEur Neuropsychopharmacol200616(Suppl)3S1495516872808
   PubMed Web of Science ®Google Scholar
• HiroehUApplebyLMortensenPBDeath by homicide, suicide, and other unnatural causes in people with mental illness: a population-based studyLancet200135821101211784624
   PubMed Web of Science ®Google Scholar
• JinHMeyerJMJesteDVAtypical antipsychotics and glucose dysregulation: a systematic reviewSchizophr Res20047119521215474892
   PubMed Web of Science ®Google Scholar
• KaneJMBarretEJCaseyDEMetabolic effects of treatment with atypical antipsychoticsJ Clin Psychiatry20046514475515554755
   PubMed Web of Science ®Google Scholar
• KaterndahlDATaylorRBProblemas conductuales y psiquiátricosMedicina de familia, principios y práctica19955New YorkSpringer289331
   Google Scholar
• KokkinosPPanagiotakosDBPolychronopoulosEDietary influences on blood pressure: the effect of the Mediterranean diet on the prevalence of hypertensionJ Clin Hypertens (Greenwich)200571657015785158
   PubMedGoogle Scholar
• LambertsHWoodMHofmans-OkkesIMThe International Classification of Primary Care in the European Community. With a multi-language layer1993OxfordOxford University Press
   Google Scholar
• MackinPWatkinsonHMYoungAHPrevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional studyDiabetologia2005482152115688206
   PubMed Web of Science ®Google Scholar
• McIntyreRSMcCannSMKennedySHAntipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalitiesCan J Psychiatry2001462738111320682
   PubMed Web of Science ®Google Scholar
• MorganMGScullyPJYoussefHAProspective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural IrelandPsychiatry Res20031171273512606015
   PubMed Web of Science ®Google Scholar
• [NCEP] National Cholesterol Education Program – Expert Panel on Detection, Evaluation, and Treatment on High Blood Cholesterol in Adults (Adult Treatment Panel III)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III final reportCirculation2002106314342112485966
   PubMedGoogle Scholar
• Orden de la Generalitat de Catalunya de 22 de diciembre deDiari Oficial de la Generalitat de Catalunya19952148968990
   Google Scholar
• Pujol-DomenechJde-Azpiazu-ArtigasPAntipsychotics in the elderly: typical or atypicalMed Clin (Barc)20061264151716595086
   PubMed Web of Science ®Google Scholar
• RyanMCThakoreJHPhysical consequences of schizophrenia and its treatment: the metabolic syndromeLife Sci2002712395712034344
   PubMed Web of Science ®Google Scholar
• SchneiderLSDagermanKInselPSEfficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trialsAm J Geriatr Psychiatry20061419121016505124
   PubMed Web of Science ®Google Scholar
• TandonRNasrallahHASubjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent dosesArch Gen Psychiatry200663935716894070
   PubMed Web of Science ®Google Scholar
• ThompsonSGBarberJAHow should cost data in pragmatic randomised trials be analysed?BMJ2000320119720010784550
   PubMed Web of Science ®Google Scholar
• UstunTBThe global burden of mental disordersAm J Public Health19998913151810474545
   PubMed Web of Science ®Google Scholar
• VázquezJLGarcíaJSimónJAMental health in primary care. An epidemiological study of morbidity and use of health resourcesBr J Psychiatry1997170529359330019
   PubMed Web of Science ®Google Scholar
• VediaCBonetSForcadaCEstudio de utilización de psicofármacos en atención primariaAten Primaria2005362394716194490
   PubMedGoogle Scholar
• [WHO] World Health Organization Collaborating Centre for Drug Statistics and MethodologyGuidelines for ATC classification and DDD assignment1995Oslo, NorwayWHO
   Google Scholar
• WoodwardNDPurdonSEMeltzerHYA meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effectsSchizophr Res2007892112417059880
   PubMed Web of Science ®Google Scholar
• WuRRZhaoJPLiuZNEffects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophreniaPsychopharmacology (Berl)2006186572816601995
   PubMed Web of Science ®Google Scholar